MedTrace Logo

Efficacy of Pergoveris in Aged IVF Patients

NCT02244866 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2014-12-25

No results posted yet for this study

Summary

To compare the efficacy between LH supplementation (Pergoveris) and non-LH supplementation (Follitropin alpha) in patients aged ≥ 35 years undergoing IVF treatment.

Study hypothesis: Pergoveris (LH supplementation) is better than follitropin alpha (non-LH supplementation) for ovarian stimulation in aged IVF patients.

Conditions

Interventions

DRUG

Pergoveris (FSH and LH)

Drugs are injected subcutaneously everyday until ovarian follicles reach 17mm in diameter.

DRUG

Follitropin alpha (FSH)

Drugs are injected subcutaneously everyday until ovarian follicles reach 17mm in diameter.

Sponsors & Collaborators

  • Vietnam National University

    lead OTHER

Principal Investigators

  • Tuong M Ho, MD · CGRH, School of Medicine, Vietnam National University HCMC, Vietnam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-04-30
Completion
2014-06-30

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02244866 on ClinicalTrials.gov